CRP and heart failure: More than half of the patients withatherosclerotic cardiovascular disease are associated with systemic inflammation.The incidences of major adverse cardiovascular events (MACEs), heart failure(HF), and mortality increase significantly when the C-reactive protein (CRP)levels are ≥2 mg/L [11].